Cisatracurium pharmacodynamics in patients with oculopharyngeal muscular dystrophy

Anesthesia and Analgesia

Volumn 100, Issue 2, 2005, Pages 393-397

  Caron, Marie Josée ^a   Girard, François ^a   Girard, Dominique C ^a   Boudreault, Daniel ^a   Brais, Bernard ^a   Nassif, Edgard ^a   Chouinard, Philippe ^a   Ruel, Monique ^a   Duranceau, André ^a  

^a NOTRE DAME HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CISATRACURIUM; FENTANYL; MIDAZOLAM; MIVACURIUM; NITROUS OXIDE; PROPOFOL;

ADULT; AGED; ANESTHESIA INDUCTION; ANESTHETIC RECOVERY; ARTICLE; BLEEDING; BOLUS INJECTION; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CRICOPHARYNGEAL MYOTOMY; DEMOGRAPHY; DISEASE SEVERITY; DOSE CALCULATION; DRUG MECHANISM; FEMALE; GENERAL ANESTHESIA; GOOD CLINICAL PRACTICE; GOOD CLINICAL RESEARCH PRACTICE; HUMAN; MALE; MYOTOMY; NEUROMUSCULAR BLOCKING; NEUROMUSCULAR DISEASE; NEUROMUSCULAR TRANSMISSION; OCULOPHARYNGEAL MUSCULAR DYSTROPHY; OPERATION DURATION; PHARMACODYNAMICS; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

ADULT; AGED; AGED, 80 AND OVER; ANESTHESIA, GENERAL; ATRACURIUM; FEMALE; HUMANS; MALE; MIDDLE AGED; MUSCULAR DYSTROPHY, OCULOPHARYNGEAL; NEUROMUSCULAR NONDEPOLARIZING AGENTS; SYNAPTIC TRANSMISSION;

EID: 12844277302     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ANE.0000140783.39597.FD     Document Type: Article

References (21)

1. Taylor EW. Progressive vagus glossopharyngeal paralysis with ptosis: a contribution to the group of family disease. J Nerv Ment Dis 1915;42:124-39.
2. Brais B, Bouchard JP, Xie YG, et al. Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy. Nat Genet 1998;18:164-7.
3. Brais B, Rouleau GA, Bouchard JP, et al. Oculopharyngeal muscular dystrophy. Semin Neurol 1999;19:59-66.
4. Duranceau AC, Beauchamp G, Jamieson GG, Barbeau A. Oropharyngeal dysphagia and oculopharyngeal muscular dystrophy. Surg Clin North Am 1983;63:825-32.
5. Landrum AL, Eggers CWN. Oculopharyngeal dystrophy: an approach to anesthetic management. Anesth Analg 1992;75: 1043-5.
6. Chun R. Safe use of mivacurium in oculopharyngeal muscular dystrophy. Can J Anaesth 1998;45:1134.
7. Viby-Mogensen J, EnglBaek J, Eriksson LI, et al. Good clinical research practice (GCRP) in pharmacodynamic studies of neuromuscular blocking agents. Acta Anaesthesiol Scand 1996;40: 59-74.
8. Egan TD, Talmage D, Huizinga B, et al. Remifentanil pharmacokinetics in obese versus lean elective surgery patients. Anesthesiology 1998;89:562-73.
9. Bouillon T, Shafer SL. Does size matter? Anesthesiology 1998; 89:557-60.
10. Duranceau A. Pharyngeal and cricopharyngeal disorders. In: Pearson GF, ed. Esophageal surgery. New York: Churchill Livingstone, 1995:389-415.
11. Ririe DG, Shapiro F, Sethna NF. The response of patients with Duchenne's muscular dystrophy to neuromuscular blockade with vecuronium. Anesthesiology 1998;88:351-4.
12. Dresner DL, Ali HH. Anesthetic management of a patient with facioscapulohumeral muscular dystrophy. Br J Anaesth 1989;62: 331-4.
13. Stackhouse R, Chelmow D, Dattel BJ. Anesthetic complications in a pregnant patient with nemaline myopathy. Anesth Analg 1994;79:1195-7.
14. Heard SO, Kaplan RF. Neuromuscular blockade in a patient with nemaline myopathy. Anesthesiology 1983;59:588-90.
15. Donati F. Onset of action of relaxants. Can J Anaesth 1988;35: S52-8.
16. Blumen SC, Brais B, Korczyn AD, et al. Homozygotes for oculopharyngeal muscular dystrophy have a severe form of the disease. Ann Neurol 1999;46:115-8.
17. Fan X, Dion P, Laganière J, et al. Oligomerization of polyalanine expanded PABPN1 facilitates nuclear protein aggregation that is associated with cell death. Hum Mol Genet 2001;10:2341-51.
18. Xue FS, Liao X, Liu JH, et al. Dose-response curve and time-course of effect of vecuronium in male and female patients. Br J Anaesth 1998;80:720-4.
19. Semple P, Hope DA, Clyburn P, Rodbert A. Relative potency of vecuronium in male and female patients in Britain and Australia. Br J Anaesth 1994;72:190-4.
20. Houghton IT, Aun CST, Oh TE. Vecuronium: an anthropometric comparison. Anaesthesia 1992;47:741-6.
21. Schmith VD, Fiedler-Kelly J, Phillips L, Grasela TH. Prospective use of population pharmacokinetics/pharmacodynamics in the development of cisatracurium. Pharm Res 1997;14:91-7.